Major Rating Factors:
Weak overall results on stability tests (1.6 on a scale of 0 to 10) including weak risk adjusted capital in prior years, weak risk diversification and weak results on operational trends. The largest net exposure for one risk is high at 3.7% of capital. Fair reserve development (3.7) as reserves have generally been sufficient to cover claims. In 2023 the two year reserve development was 55.2% deficient. Good overall profitability index (5.4) despite operating losses during 2022.
Other Rating Factors:
Strong long-term capitalization index (7.3) based on excellent current risk adjusted capital (severe and moderate loss scenarios) reflecting significant improvement over results in 2023. Excellent liquidity (7.0) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
MT
Principal Investments:
Common stock (44.4%), investment grade bonds (33.4%), cash (22.2%)
Ratios
Premium to Surplus
Reserve to Surplus
1-Year Reserve Development
2-Year Reserve Development
Expense Ratio
Combined Ratio
Cash From Underwriting
Net Premium Growth
Investments in Affiliates
--
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
108 Crestview Drive
Bigfork, MT 59911
Bigfork, MT 59911
Phone Number
(406) 282-0170
NAIC Number
13067
Website
--
Largest Affiliates
No affiliate information available.